VIDEO: People with Parkinson’s freeze for ‘mannequin challenge’
Author: Almaz OhenePublished: 5 January 2017
Prep: Cook: Serves:
Parkinson’s campaigners worldwide are taking up the ‘mannequin challenge’ – the latest social media trend to sweep the web – to show that ‘freezing’ is part of everyday life for many people with the condition
To share the reality of ‘freezing of gait’, major Parkinson’s organisations around the world have filmed their own versions of the popular social media trend, the #MannequinChallenge. Here are three of the most popular – from Parkinson’s UK, the Parkinson Voice Project in the US and Parkinson’s NSW in Australia.
It launched a campaign featuring four videos showing people unable to move in everyday scenarios such as crossing the street, making a cup of tea and answering the front door.
The emotive messaging asks viewers to “Donate. Now. So their challenge can end.”
2. Parkinson Voice Project
Patients at the Parkinson Voice Project’s clinic in Texas, US, showed viewers the interactive and dynamic nature of their regular speech therapy classes, as they pause for a minute for the camera stunt.
3. Parkinson’s NSW
The Australian organisation took a different approach and focused on people with Parkinson’s tremors among those frozen in time.
4. Vlaamse Parkinson Liga
This challenge was an initiative by a group from Ghent, Belgium who are part of the Vlaamse Parkinson Liga (VPL), the Flemish Parkinson’s disease association. They wanted to highlight the fact that although Parkinson’s patients freeze due to stability problems, it’s also difficult to freeze on demand. The organisation’s president is Yves Meersman, who is also the lead chef behind the Parki’s Kookatelier project.
First it was ‘planking’, then came the ice bucket challenge, and now ‘mannequin challenge’ videos are sweeping the web – a viral internet video trend where people remain frozen in action like mannequins while a moving camera films them.
‘Which Way Up’: documentary following painter John McLean
UK screening of film about painter with Parkinson’s, John McLean
3 weeks ago
Excess calcium in brain could cause Parkinson’s
Researchers at the University of Cambridge, UK, have discovered that excess levels of calcium in brain cells may lead to the formation of the toxic clusters that signify Parkinson’s disease. The findings, reported in the journal ‘Nature Communications’, show that calcium can influence the interaction between small membranous structures inside nerve endings, which are important for neuronal signaling in the brain, and alpha-synuclein – the protein associated with Parkinson’s disease. Dr Janin Lautenschläger, the paper’s first author, said: “This is the first time we’ve seen that calcium influences the way alpha-synuclein interacts with synaptic vesicles. We think that alpha-synuclein is almost like a calcium sensor. In the presence of calcium, it changes its structure and how it interacts with its environment, which is likely very important for its normal function.”
Jewish people with Crohn’s disease more likely to carry LRRK2 gene mutation
A scientific study has concluded that there may be a link between Parkinson’s and Crohn’s disease within the Ashkenazi Jewish community. The study’s findings, which were published in the journal ‘Science Translational Medicine’, has found that members of the population with Crohn’s disease are more likely to carry the LRRK2 mutation which is a significant cause of Parkinson’s. Lead researcher Dr Inga Peter, professor of genetics and genomic sciences at the Icahn School of Medicine, New York, US, said: “Crohn’s disease is a complex disorder with multiple genes and environmental factors involved, which disproportionately affects individuals of Ashkenazi Jewish ancestry. “The presence of shared LRRK2 mutations in patients with Crohn’s disease and Parkinson’s disease provides refined insight into disease mechanisms and may have major implications for the treatment of these two seemingly unrelated diseases.”
Could caffeine in the blood help diagnose Parkinson’s?
Blood caffeine levels could be promising diagnostic biomarkers for early-stage Parkinson’s, Japanese researchers reported in the journal ‘Neurology’ earlier this month. The study found that people with Parkinson’s had lower levels of caffeine and caffeine metabolites in their blood than people without the disease, at the same consumption rate. Caffeine concentrations also were decreased in Parkinson’s patients with motor fluctuations than in those without Parkinson’s. However, patients in more severe disease stages did not have lower caffeine levels. The study’s authors, Dr David Munoz, University of Toronto, and Dr Shinsuke Fujioka, Fukuoka University, suggested that the “decrease in caffeine metabolites occurs from the earliest stages of Parkinson’s.” They added: “If a future study were to demonstrate similar decreases in caffeine in untreated patients with Parkinson’s […] the implications of the current study would take enormous importance.”